| LYRAX | VEVYX | LYRAX / VEVYX | |
| Total Expense Ratio | 1.24 | 0.66 | 188% |
| Annual Report Gross Expense Ratio | 1.67 | 0.66 | 253% |
| Fund Existence | 4 years | 14 years | - |
| Gain YTD | 16.011 | 14.367 | 111% |
| Front Load | 6% | N/A | - |
| Min. Initial Investment | 1000 | 1000000 | 0% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 1.31B | 15.1B | 9% |
| Annual Yield % from dividends | 0.00 | 1.12 | - |
| Returns for 1 year | 17.03 | 12.17 | 140% |
| Returns for 3 years | 60.60 | 10.38 | 584% |
| Returns for 5 years | N/A | 8.04 | - |
| Returns for 10 years | N/A | 70.65 | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| FSENX | 85.94 | 0.70 | +0.82% |
| Fidelity Select Energy Portfolio | |||
| GSILX | 23.19 | N/A | N/A |
| Goldman Sachs GQG Ptnrs Intl Opps C | |||
| HSIIX | 29.59 | -0.08 | -0.27% |
| Carillon Eagle Small Cap Growth I | |||
| CCWSX | 21.56 | -0.16 | -0.74% |
| Baird Chautauqua International Gr Inv | |||
| RYOAX | 66.89 | -1.55 | -2.26% |
| Rydex Biotechnology H | |||